Drugs

Biological Agents for Rheumatoid Arthritis: Targeting Both Physical Function and Structural Damage
pp. 1267-1283(17)
Author: Klinkhoff A.

Recent Advances in Understanding the Pathogenesis of Polycystic Kidney Disease: Therapeutic Implications
pp. 1285-1294(10)
Author: Cowley Jr B.D.

Management of Fatigue in Patients with Multiple Sclerosis
pp. 1295-1304(10)
Author: Zifko U.A.

Fluvastatin: Clinical and Safety Profile
pp. 1305-1323(19)
Authors: Corsini A.; Jacobson T.A.; Ballantyne C.M.

Immunosuppression for Long-Term Maintenance of Renal Allograft Function
pp. 1325-1338(14)
Author: Offermann G.

The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
pp. 1339-1358(20)
Author: Rendell M.

Role of Fluoroquinolones in the Treatment of Serious Bacterial Urinary Tract Infections
pp. 1359-1373(15)
Authors: Carson C.; Naber K.G.

Somatropin (Zorbtive™): In Short Bowel Syndrome
pp. 1375-1381(7)
Authors: Keating G.M.; Wellington K.

Somatropin (Zorbtive™): A Viewpoint by Bernard Messing
pp. 1382-1383(2)
Author: Messing B.

Somatropin (Zorbtive™): A Viewpoint by John K. DiBaise
pp. 1382-1383(2)
Author: DiBaise J.K.